Atyr Pharma Inc (NASDAQ: ATYR) kicked off on Monday, at the price of On Monday, down -2.39% from the previous trading day, before settling in for the closing price of $3.35. Over the past 52 weeks, ATYR has traded in a range of $1.42-$4.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 429.49% over the last five years. While this was happening, its average annual earnings per share was recorded 17.86%. With a float of $86.00 million, this company’s outstanding shares have now reached $88.86 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is -390.64%, operating margin of -28899.57%, and the pretax margin is -27243.4%.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 3.22%, while institutional ownership is 62.93%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.86% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Take a look at Atyr Pharma Inc’s (ATYR) current performance indicators. Last quarter, stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1263.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.87, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Analysing the last 5-days average volume posted by the [Atyr Pharma Inc, ATYR], we can find that recorded value of 1.15 million was lower than the volume posted last year of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 64.26%. Additionally, its Average True Range was 0.27.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 41.10%, which indicates a significant decrease from 66.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.30% in the past 14 days, which was lower than the 83.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.40, while its 200-day Moving Average is $2.88. Now, the first resistance to watch is $3.47. This is followed by the second major resistance level at $3.68. The third major resistance level sits at $3.82. If the price goes on to break the first support level at $3.13, it is likely to go to the next support level at $2.99. Now, if the price goes above the second support level, the third support stands at $2.78.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
The company with the Market Capitalisation of 290.57 million has total of 88,859K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -64,020 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -14,970 K.
